Sharemaestro company report · Improving combined scores · TOR

Helix BioPharma Corp.

HBP · The selected case has incomplete evidence

1 of 3 available weekly market readings are positive.

The selected research question · Improving combined scores

Is the improvement broadening?

An improving combined score is more useful when several pillars improve together. Check what changed and whether the company period changed too.

Breadth behind the score

The selected case has incomplete evidence

Some core readings or input coverage are missing or limited. The selected screen can still have a result, but the wider company interpretation needs more evidence.

Latest change: 5 improving, 0 weakening and 0 unchanged across the 5 comparable focus pillars since the previous edition.

2/5 strong
Focus pillars with standing ≥65. This is a breadth check, not a new combined score.
Value
62/100

+3.5 points vs screen median

Strong in 0% of 17 observed editions
Business strength
63/100

+5.0 points vs screen median

Strong in 0% of 17 observed editions
Price strength
64/100

+5.0 points vs screen median

Strong in 0% of 17 observed editions
Growth
65/100

+9.0 points vs screen median

Strong in 18% of 17 observed editions
Capital return
65/100

+5.0 points vs screen median

Strong in 6% of 17 observed editions

The comparison uses companies qualifying for this screen in the same universe and edition. Medians require at least five companies. Historical strength counts actual factor observations; it does not claim historical screen membership.

01 · The company in perspective

The shape of the evidence

Higher means stronger relative standing.
Value62/100
+16.0 points vs Healthcare median
Business strength63/100
+16.0 points vs Healthcare median
Price strength64/100
+18.0 points vs Healthcare median
Growth65/100
+7.0 points vs Healthcare median
Capital return65/100
+25.0 points vs Healthcare median

Vertical marks show the peer median · 45 company records in the comparison.

Current research reading

Partial evidence

The available record does not support a complete comparison.

Review coverage before relying on the combined score.

Strongest pillar

Growth

65/100 standing

Weakest pillar

Value

62/100 standing

The strongest and weakest pillars describe this profile, not changes in company performance. The history below shows whether the readings are improving.

02 · Market confirmation

Is the price supporting the case?

Full chart terminal ↗
Trend SignalNot positivelatest completed chart observation
Market DynamicsPositivelatest completed chart observation
Relative StrengthNot positivelatest completed chart observation
Price / Fair Value-22.5%positive is above the reference

03 · What is changing

A strong reading matters more when it lasts.

7 Jun 2026 – 25 Sep 2026
Factor standing, one edition at a time

Read across for persistence. Read down for breadth. Each cell is an actual published observation.

80–9965–7940–640–39No reading
Company factor history. Higher scores mean stronger standing in the comparison universe.
Factor7 Jun202614 Jun202621 Jun202628 Jun20265 Jul202612 Jul202619 Jul202626 Jul20262 Aug20269 Aug202616 Aug202623 Aug202630 Aug20264 Sep202611 Sep202618 Sep202625 Sep2026LatestChange
CombinedFocus77+37.0points
ValueFocus62+18.0points
Business strengthFocus63+18.0points
Price strengthFocus64+18.0points
GrowthFocus65+18.0points
Capital returnFocus65+18.0points

Hover or focus a cell to inspect its dated reading. Arrow keys move between factors and editions. Scroll across for more dates.

Changes since the previous edition
Value+18.0 pts44 → 62
Business strength+18.0 pts45 → 63
Price strength+18.0 pts46 → 64
Growth+18.0 pts47 → 65
Capital return+18.0 pts47 → 65

Changes compare 18 Sep 2026 with 25 Sep 2026. The underlying company period did not change between these editions. Prices, peer rankings and other inputs can still move the scores. Changes in a relative score do not, by themselves, identify a cause.

04 · Competitive position

Company strength, in its peer context

Explore Healthcare ↗

Value and Business strength

HBP is highlighted against companies in the Improving combined scores screen. Select a point to compare the same research angle. Up to 250 companies shown.

Has price kept pace?

Price returns to 25 Sep 2026. The comparison is the median of companies in the same sector with a reading, not a traded portfolio.

3 monthsHBP-29.0%Sector median0.0%Difference-29.0 pp
6 monthsHBP-44.0%Sector median9.0%Difference-53.0 pp
12 monthsHBP-35.2%Sector median-3.7%Difference-31.6 pp

Relative standing is the useful comparison.

A rising share price can still trail its peers. A company with falling prices can still outperform a weaker sector. Compare the return gap with the factor profile before drawing a conclusion.

At least five sector observations are required to display a median. Returns exclude dividends. These are completed historical returns, not forward estimates.

05 · Staying power and price risk

Separate company standing from the ride.

Strong factor evidence does not remove price risk.
Combined factor standing · strong editions18%score ≥65 in 17 observed editions
Annualised volatility74.0%stored one-year daily measure · factor date
Input coverage42%available factor inputs, not certainty

Drawdown measures the weekly close below its running high within the displayed price history. It starts at zero and is not an all-time drawdown. Persistence counts observed editions only; missing weeks are not filled in.

06 · Research playbook

What would strengthen — or weaken — this reading?

Conditions to monitor, not a trade instruction.
Build the Improving combined scores case

Several pillars strengthen together

Compare changes across all five perspectives; watch for new company inputs and loss of price support.

1 of 3 available weekly market readings are positive.

Challenge the case

The score depends on fewer strong pillars

Value is the weakest measured focus pillar at 62/100. Check whether it is recovering, stable or deteriorating in the history above.

A loss of screen qualification, lower coverage or deterioration across several readings would require a fresh review.

Compare the alternatives

Keep the research question consistent

Compare HBP with other companies selected by Improving combined scores. A stronger overall score does not necessarily mean stronger evidence for this particular approach.

Open this screen →

Screen membership

Where HBP qualifies

The same selection rules used by the Company Screener.

A traceable Sharemaestro report

Built from the record we have.

This report uses published Sharemaestro factor snapshots and stored completed weekly prices and indicators. Company inputs are translated into comparable standing, change and context. The page does not fetch live accounts or infer missing company results.

Scores use the established higher-is-stronger Sharemaestro display convention and are relative to Canada - CAD. Sector medians compare those same universe scores; they do not re-rank the company. Peer medians exclude missing readings.

The company period is the period end used in the factor edition, not its filing date. Stored history is an observation record, not a claim of a point-in-time investable backtest. None of these scores is a probability or expected return.

Historical price series may reflect provider adjustments. The combined score is a summary, not a substitute for the distinct strengths, weaknesses and data coverage shown above.

Evidence context